Is Right to Choose right for your business?

Drawing on their work with independent NHS and non-NHS providers, Michelle Snook and Guy Gross, Managing Partners at healthcare advisory firm Regulum, share the questions providers should work through before deciding whether Right to Choose is right for their business.
Pascale Day
Head of Content
Tonks
Pawlice

For independent providers considering Right to Choose, demand is rarely the biggest unknown. The more important question is whether your organisation can deliver the whole pathway safely and sustainably within the way NHS services are commissioned and funded.

Patient demand is high, NHS waiting lists remain under pressure and independent providers can play an important role in increasing capacity. But before committing time, money or your workforce, you need to understand what the service will really take to run.

Start with the pathway, not the size of the waiting list

Waiting-list size is only one part of the commercial picture. What really matters is how much funded activity you’re realistically likely to deliver, what the pathway will cost and how much control you actually have over volume.  

Before making a decision, build a realistic picture of the service you would actually need to run. Ask yourselves:

  • Do we fully understand the qualifying contract and accreditation requirements?
  • Can we deliver the whole pathway required by the contract, rather than only the most commercially attractive element (as that’s what will be required in future commissioning arrangements)?
  • Have we included clinical time, administration, governance, prescribing & drug costs, data reporting, quality assurance, complaints and regulatory compliance in our cost model?
  • Can we manage referrals across multiple Integrated Care Boards (ICBs), each with potentially different service specifications and arrangements?
  • Do we have sufficient working capital if supplier onboarding or payment takes longer than expected?
  • What would happen if tariffs reduced, or an ICB restricted activity after we had already invested in workforce and infrastructure?

This is where a little pessimism can actually be useful. A business case built around high referral volumes and steady growth might look attractive, but a far more useful test is whether the service still works when activity is lower than expected, payment takes longer or the cost of delivering care increases.  

A useful first step

Before you invest heavily, make sure you understand the contract, the pathway you’ll be expected to deliver and the operational requirements that come with it. The aim at this stage is to make sure you’re assessing the real service, not just the size of the opportunity.

What does the whole pathway really cost?

One of the easiest mistakes to make is focusing on the headline tariff for an assessment. Instead, you should start from the moment a referral arrives and follow the pathway all the way through – the assessment itself may only account for one part of the work.

Depending on the service, that could include referral validation, triage, diagnosis, reporting, feedback, prescribing, titration, shared care, annual reviews and discharge.

Then take a look at the costs sitting behind each stage, which might include:

  • The time of each healthcare professional involved
  • Clinical supervision and multidisciplinary review
  • Administrative and medical-secretarial support
  • Prescribing and medication management
  • Drug costs  
  • Digital systems and information governance
  • Data reporting and invoice validation
  • Quality audits, complaints and safeguarding
  • Non-attendance and rework
  • Additional time for more complex patients
  • Ongoing care where shared care isn’t accepted

That last point can become particularly important in pathways such as adult ADHD, where providers might assume patients will eventually move into shared care with their GP.

If shared care is declined, you might remain responsible for ongoing prescribing and monitoring, creating a much larger long-term clinical and operational commitment than the initial assessment model suggests. Across hundreds or thousands of patients, that can become a significant ongoing clinical and operational commitment.

Start with the numbers

At Regulum, we map the pathway stage by stage and attach a real cost to each part. We then stress-test the model against different referral volumes and complexity levels.  

Then we check exactly what the NHS tariff covers; don’t assume that because something is clinically necessary, the cost is automatically included in the tariff. The aim is to understand your fully loaded cost of the whole pathway rather than judging the opportunity on only the assessment.

Build for the likely volume, not the ideal volume

Right to Choose providers don’t operate in a market where they control every part of demand or funding. ICBs may use mechanisms such as Indicative Activity Plans (IAPs), Activity Management Plans (AMPs), prior approval processes or Single Points of Access (SPoAs) to manage activity and expenditure.

We’ll explore these mechanisms in more detail elsewhere in this toolkit, but this commercial point is important to remember: patient demand doesn’t necessarily translate directly into funded activity.

This is key to understand if you’ve recruited clinicians, built operational teams or invested in infrastructure based on a much higher forecast. If funded activity is then lower than expected, those costs don’t disappear with it.

Base your plan on what’s likely to be funded

Build your workforce plan around realistic, funded activity rather than the maximum number of patients who could theoretically be referred. Ask yourselves what would happen if volumes fluctuated and how quickly your organisation could adapt without affecting patient care.

Use flexibility to improve the pathway

Independent providers often have an advantage when designing new services, because they tend to have fewer legacy structures to work around. This makes it far easier to build the operation around the patient pathway itself rather than fitting it into a historic NHS Trust organisational structure.

Depending on the service, that could mean more flexible clinical sessions, remote appointments (where appropriate), focused admin teams, a geographically dispersed workforce or quicker adoption of digital tools like automated reminders and structured questionnaires.

High-volume surgical pathways like cataract care are a good example of this in action. Dedicated independent facilities can sometimes structure teams, theatres and workflows around one repeatable pathway rather than fitting that service into a multipurpose hospital environment.

The same principle can apply beyond surgery too: when the service is designed around the pathway, there are more opportunities to reduce duplication and unnecessary handovers.

That flexibility, however, should never come at the expense of clinical quality or governance. You still need robust clinical governance, safe prescribing, information governance, quality assurance, reporting and regulatory compliance.

So where should you focus your attention?

Keep it simple: look for places where your service design can remove unnecessary admin or handovers while keeping the safeguards that good care needs.

Should Right to Choose be your only source of activity?

In our view, Right to Choose is generally more resilient as part of a broader, carefully managed mix than as the organisation’s only source of activity.

Right to Choose can give you access to NHS-funded patients and support growth. At the same time, tariffs, regional requirements, activity levels and payment timing may all sit partly outside your control. A broader model could mean combining Right to Choose with other NHS contracts, private services or additional service lines.

There can also be operational advantages to a mixed model. It can diversify financial risk, and allows infrastructure, workforce and governance systems to support several parts of the organisation rather than existing solely for one funding stream.

The important caveat is that NHS and private pathways need to remain operationally and financially clear. Waiting lists, patient prioritisation, staff capacity, pricing and communications all need appropriate rules so that one pathway doesn’t adversely affect another.

Sense-check your dependency

Look at how much of your organisation’s income, workforce and infrastructure would depend on Right to Choose. The greater that dependency, the more exposed you are to changes in tariffs, activity or local commissioning arrangements.

A diversified model won’t be right for every provider, but understanding the level of dependency is an important part of the decision.

Don’t scale faster than the funding

High patient demand can create pressure to recruit quickly, which that becomes risky if workforce growth is based on anticipated referrals rather than confirmed or likely funded activity.

You might recruit clinicians, admin staff and operational support expecting demand to continue at a particular level, only for an ICB to restrict activity later, and your organisation is then left carrying the cost.

Payment timing can create a similar pressure: you might need to fund delivery before you’re fully onboarded with a commissioner or before invoices are paid. As such, working capital then matters just as much as the headline margin.

Plan for the worst-case scenario

Good strategic planning should include a downside consideration – this is the point to test what happens when the assumptions move against you.  

Build cash-flow scenarios alongside your profit-and-loss model and ask:

  • How long could the organisation operate if payment was delayed?
  • What costs continue if activity drops?
  • How quickly can workforce capacity adjust?
  • Which patients would you still have an ongoing responsibility to support?
  • What happens if tariffs reduce after you’ve invested in the service?

We know these are hard questions to ask, but they give you a much more useful, realistic picture of whether the model is sustainable.

So, is Right to Choose right for your business?

We’ll be honest: there’s no universal answer.

For some providers, Right to Choose can create an opportunity to increase NHS capacity, reach more patients and build a significant new service.

It’s really crucial before committing significant time or money that you understand the fully loaded cost of delivering the complete pathway safely at the level of activity you realistically expect to be funded for, and the amount of risk your organisation can absorb.

That’s the business case we’d want to see: one built around the realities of delivering the service, not just the demand for it. One that still works even when the assumptions become less favourable.

If the model can absorb those pressures, you’re starting from a much stronger position. If it can’t? Well, finding that out before you scale is valuable in itself.

Featured

Is Right to Choose right for your business?
Is Right to Choose right for your business?
No items found.
Ready to join thousands that already trust Semble?
4.5 Capterra
4.3 Google